Cascadian Therapeutics Inc (USA) Share Price

Stocks

04/01/18	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	GL
02/01/18	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	GL
13/12/17	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	GL
07/12/17	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	GL
08/11/17	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0.50%	-	-	0
ARGENX SE	-1.53%	+0.78%	+72.33%	+129.70%	56.71B
WUXI APPTEC CO., LTD.	-2.45%	-7.83%	+63.92%	+83.15%	51.3B
INSMED INCORPORATED	+3.27%	+8.91%	+21.21%	+486.76%	25.26B
BIONTECH SE	-0.81%	-0.42%	-16.24%	-12.47%	23.65B
WUXI BIOLOGICS (CAYMAN) INC.	+3.48%	+3.29%	+43.01%	-2.53%	18.69B
GENMAB A/S	-0.24%	+5.11%	+38.76%	-26.41%	17.71B
PHARMAESSENTIA CORPORATION	+2.34%	+12.50%	+224.02%	+380.99%	17.7B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.79%	+1.24%	+35.33%	-	14.26B
EXELIXIS, INC.	-1.70%	+3.98%	+28.96%	+190.57%	14.1B
Average	+0.15%	+4.02%	+56.81%	+153.72%	26.6B
Weighted average by Cap.	-0.34%	+2.20%	+58.07%	+144.53%

Employees

Sector